首页> 外文期刊>Journal of Clinical Pathology >Breast cancer stem cells: an update
【24h】

Breast cancer stem cells: an update

机译:乳腺癌干细胞:最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Breast cancer is a significant cause of morbidity and mortality in women with a high incidence of recurrence or treatment failure. Growing evidence suggests that cancer stem cells (CSCs) most likely contribute to tumour progression, spread and therapy failure. However, despite extensive research and the tremendous clinical potential of such cells in possible therapeutic management, the real nature of CSCs remains an enigma. In this review, we discuss the fundamental properties and molecular target of CSCs and focus on recent advances regarding the identification of CSC markers with emphasis on breast cancer and the underlying molecular mechanism of CSC phenotypes. We also discuss experimental evidence of targeting molecular pathways in order to modulate breast CSC behaviour in tumourigenesis and the controversies associated with it that potentially weaken the CSC model in breast cancer and other cancers as well.
机译:乳腺癌是导致复发或治疗失败的女性高发病率和死亡率的重要原因。越来越多的证据表明,癌症干细胞(CSC)最有可能导致肿瘤进展,扩散和治疗失败。然而,尽管进行了广泛的研究并且这种细胞在可能的治疗管理中具有巨大的临床潜力,但CSC的真正本质仍然是一个谜。在这篇综述中,我们讨论了CSCs的基本特性和分子靶标,并着重于有关CSC标志物鉴定的最新进展,重点是乳腺癌和CSC表型的潜在分子机制。我们还讨论了靶向分子途径的实验证据,目的是调节肿瘤发生中的乳腺CSC行为以及与此相关的争议,这些争议可能削弱乳癌和其他癌症中的CSC模型。

著录项

  • 来源
    《Journal of Clinical Pathology》 |2013年第6期|485-490|共6页
  • 作者单位

    Department of Pathology, Singapore General Hospital, One Hospital Drive, Singapore 169608, Singapore;

    Department of Pathology, Singapore General Hospital, Singapore, Singapore;

    Department of Pathology, Singapore General Hospital, Singapore, Singapore;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号